ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

This article was originally published here

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the company will be developing the

The post ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply